Karpas Strategies LLC held its position in Colgate-Palmolive Company (NYSE:CL) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 10,000 shares of the company’s stock at the end of the second quarter. Karpas Strategies LLC’s holdings in Colgate-Palmolive were worth $741,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in CL. Blue Chip Partners Inc. boosted its position in Colgate-Palmolive by 0.4% in the first quarter. Blue Chip Partners Inc. now owns 1,805 shares of the company’s stock worth $132,000 after buying an additional 8 shares during the period. Alpha Windward LLC boosted its position in Colgate-Palmolive by 0.6% in the first quarter. Alpha Windward LLC now owns 2,829 shares of the company’s stock worth $207,000 after buying an additional 18 shares during the period. Northstar Group Inc. boosted its position in Colgate-Palmolive by 0.4% in the first quarter. Northstar Group Inc. now owns 4,850 shares of the company’s stock worth $356,000 after buying an additional 20 shares during the period. M Holdings Securities Inc. boosted its position in Colgate-Palmolive by 0.4% in the first quarter. M Holdings Securities Inc. now owns 5,366 shares of the company’s stock worth $393,000 after buying an additional 21 shares during the period. Finally, Capital Investment Advisors LLC boosted its position in Colgate-Palmolive by 0.3% in the second quarter. Capital Investment Advisors LLC now owns 8,318 shares of the company’s stock worth $617,000 after buying an additional 27 shares during the period. Institutional investors own 73.74% of the company’s stock.

Colgate-Palmolive Company (CL) traded down 0.17% during mid-day trading on Friday, hitting $71.48. 2,297,297 shares of the stock were exchanged. Colgate-Palmolive Company has a 52-week low of $63.43 and a 52-week high of $77.27. The stock has a market cap of $62.96 billion, a PE ratio of 26.56 and a beta of 0.80. The stock’s 50 day moving average is $73.87 and its 200 day moving average is $72.62.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.72. The firm had revenue of $3.83 billion for the quarter, compared to the consensus estimate of $3.89 billion. Colgate-Palmolive had a net margin of 15.83% and a return on equity of 3,121.95%. The company’s revenue for the quarter was down .5% on a year-over-year basis. During the same period last year, the firm posted $0.70 earnings per share. Analysts forecast that Colgate-Palmolive Company will post $2.89 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, August 15th. Stockholders of record on Tuesday, July 18th will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 2.24%. The ex-dividend date of this dividend is Friday, July 14th. Colgate-Palmolive’s dividend payout ratio is currently 59.48%.

COPYRIGHT VIOLATION NOTICE: This report was originally reported by Daily Political and is the property of of Daily Political. If you are viewing this report on another publication, it was illegally stolen and republished in violation of international copyright & trademark law. The correct version of this report can be viewed at https://www.dailypolitical.com/2017/08/06/karpas-strategies-llc-has-741000-stake-in-colgate-palmolive-company-nysecl.html.

A number of analysts have issued reports on the stock. UBS AG reiterated a “neutral” rating and issued a $78.00 price target (down from $79.00) on shares of Colgate-Palmolive in a report on Tuesday, May 2nd. Royal Bank Of Canada reiterated a “hold” rating and issued a $74.00 price target on shares of Colgate-Palmolive in a report on Monday, April 24th. Jefferies Group LLC assumed coverage on shares of Colgate-Palmolive in a report on Tuesday, April 18th. They issued a “hold” rating and a $78.00 price target on the stock. BidaskClub downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Saturday, June 24th. Finally, Wells Fargo & Company reiterated a “market perform” rating on shares of Colgate-Palmolive in a report on Monday, July 24th. Two research analysts have rated the stock with a sell rating, twelve have given a hold rating and two have given a buy rating to the stock. Colgate-Palmolive has an average rating of “Hold” and a consensus price target of $75.82.

In other news, insider Patricia Verduin sold 3,833 shares of the firm’s stock in a transaction dated Thursday, June 15th. The shares were sold at an average price of $75.67, for a total value of $290,043.11. Following the transaction, the insider now directly owns 53,022 shares of the company’s stock, valued at $4,012,174.74. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Ellen M. Hancock sold 5,057 shares of the firm’s stock in a transaction dated Tuesday, August 1st. The stock was sold at an average price of $71.91, for a total transaction of $363,648.87. Following the completion of the transaction, the director now directly owns 199,777 shares in the company, valued at $14,365,964.07. The disclosure for this sale can be found here. Over the last three months, insiders sold 117,097 shares of company stock worth $8,480,638. Insiders own 1.02% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.